DVA stock forecast
Our latest prediction for DaVita, Inc.'s stock price was made on the Dec. 8, 2017 when the stock price was at 67.71$.
In the short term (2weeks), DVA's stock price should underperform the market by -0.05%. During that period the price should oscillate between -5.14% and +4.42%.
In the medium term (3months), DVA's stock price should underperform the market by -1.12%. During that period the price should oscillate between -12.14% and +11.89%.Get email alerts
About DaVita, Inc.
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
At the moment the company generates 11365M USD in revenues.
On its last earning announcement, the company reported a profit of 3.38$ per share.
The book value per share is 25.64$
Three months stock forecastDec. 8, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|